Metro-Minnesota Community Clinical Oncology Program (MM-CCOP)

明尼苏达都会区社区临床肿瘤学计划 (MM-CCOP)

• 批准号: 9116801
• 负责人: Daniel M Anderson
• 金额: $ 258万
• 依托单位: HEALTHPARTNERS INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-01 至 2019-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9116801
• 关键词: Address; Affect; American Cancer Society; American College of Radiology Imaging Network; American College of Surgeons Oncology Group; Area; Award; Awareness; Cancer Center; Cancer Control; Cancer Information Service; Cancer Patient; Cancer Research Project; Cancer and Leukemia Group B; Caring; Chemoprevention; Clinical Oncology; Clinical Research; Clinical Trials; Clinical Trials Support Unit; Clinics and Hospitals; Collaborations; Communication; Communities; Community Clinical Oncology Program; Community Hospitals; Comprehensive Cancer Center of Wake Forest University; Controlled Study; Data; Data Collection; Decision Making; Development; Doctor of Medicine; Eastern Cooperative Oncology Group; Enrollment; Environment; Evaluation; Funding; Goals; Grant; Growth; Gynecologic Oncology; Gynecologic Oncology Group; Health; Health Care Reform; Health Planning; Health Planning Councils; Health Professional; Hematology; Hospital Administration; Hospitals; Improve Access; Institutes; Institution; Institutional Review Boards; Knowledge; Link; Malignant Neoplasms; Marketing; Medical; Minnesota; Minority Participation; Modeling; Molecular Target; National Cancer Institute; National Surgical Adjuvant Breast and Bowel Project; Natural History; North Central Cancer Treatment Group; Nursing Societies; Oncologic Nursing; Oncologist; Oncology Nurse; Operations Research; Outcome; Pamphlets; Participant; Patient Recruitments; Patients; Patterns of Care; Physicians; Primary Care Physician; Protocols documentation; Quality of life; Radiation Oncology; Radiation Therapy Oncology Group; Recording of previous events; Reporting; Research; Research Infrastructure; Research Personnel; Resources; Screening for cancer; Specialist; Surgical Oncology; System; Thoracic Surgical Procedures; Time; Toxic effect; Treatment-related toxicity; Underrepresented Populations; Underserved Population; Universities; Wisconsin; anticancer research; base; cancer care; cancer clinical trial; cancer prevention; cancer therapy; care delivery; data management; follow-up; improved; meetings; member; metropolitan; novel therapeutics; oncology program; organizational structure; programs; protocol development; racial and ethnic; research and development; research study; service utilization; success; symptom management; symptom treatment; targeted agent; underserved minority; web site

DESCRIPTION (provided by applicant): The Metro-Minnesota Community Clinical Oncology (MMCCOP) program has a long-standing history which clearly demonstrates the success of the consortium, as demonstrated by both the ongoing commitment of the original consortium members and the growth of the consortium from 1979 through 2014. The MMCCOP consortium represents an established community program base which began in 1979 through its NCI-funded Community Hospital Cancer Program (CHCP) Award. This same consortium applied for and received the initial Community Clinical Oncology Program (CCOP) grant from the NCI in 1983, and has received subsequent CCOP grants since that time. In 2010, hospital, clinics and oncologists in the MN CGOP program joined the MMCOP resulting in a metrowide community cancer research program. Currently, the MMCCOP consortium represents twenty-one hospital and clinics throughout the metropolitan and greater Minnesota area, with a common approach and established mechanisms for identifying, enrolling and following participants on NC-sponsored treatment, cancer prevention, cancer control and symptom management protocols. The health market in the MMCCCP community remains extremely competitive and is in constant change as a result of mergers and Minnesota's healthcare reform initiatives. Despite this changing environment, the MMCCOP hospitals and associated staff continue to collaborate and support the added time and expense involved in clinical research trials. Their level of support has increased during a time when many other projects within the hospitals are being reduced or eliminated. This program incorporates a substantial segment of the oncology community, and has provided a basis for communications between the practicing oncologists, their hospital administrations, and other health professionals in this consortium for the past thiry years. Combined, the consortium members see an average of over 15,000 new analytic cancer patients per year. Currently, there are 146 Investigators, representing medical, hematology, radiation and surgical oncology including thoracic surgery and gynecologic oncology. The history of MMCCOP Research Base Affiliations and proactive approach to expanding access to NCI sponsored studies supports the ability to achieve and maintain the NCI goals for this NCORP initiative. MMCCOP intends to sustain a region wide community consortium which provides the community with the most recent advances in cancer prevention, treatment, symptom management and care delivery. This will be accomplished through continued affiliations with ALL1ANCE,CTSU, ECOG-ACRIN, NRG, MD Anderson, URCC and CCCWFU, the expansion of the current MMCCOP data management and communication system to increase the number and level of participation of the investigators in accrual, program operations and research base activities, implementation of new strategies to improve access and participation of underrepresented and underserved groups, and increase the professional and lay community awareness of the benefits of cancer research and collaboration with the MMCCOP to achieve the goals of the NCORP. A new focus will be to further develop and utilize expertise and data within the consortium and community to provide data and conduct cancer care delivery research. All member institutions are members of the Institutional Review Board for the Community Oncology Programs, administered by Park Nicollet Institute, which provides an efficient and timely review of studies. Over the past 5 years an average of 250 patients and 400 patients were accrued to NCI-approved treatment studies and cancer control studies respectively. Additionally, there are 1666 participants in active follow-up or surveillanc. MMCCCOP has demonstrated the ability to enter an increasing number of patients on protocol each year and proposes to accrue a total of 260 credits to Treatment studies and 400 to Cancer Control and Cancer Care Delivery research studies in the first year of this award with the goal of increasing cancer care delivery research enrollments over the next 5 year. This is a well tuned research consortium with the ability to be fully operational on day one of the award.

描述(由申请人提供)：明尼苏达州大都会社区临床肿瘤学(MMCCOP)项目有着悠久的历史，这清楚地证明了该联盟的成功，从最初联盟成员的持续承诺和该联盟从1979年到2014年的增长都证明了这一点。MMCCOP联盟代表着一个建立起来的社区项目基础，该项目始于1979年，由NCI资助的社区医院癌症项目(CHCP)奖。这个联合体在1983年申请并获得了NCI的社区临床肿瘤学计划(CCOP)拨款，此后又获得了随后的CCOP拨款。2010年，MN CGOP计划中的医院、诊所和肿瘤学家加入了MMCOP，从而形成了一个大城市社区癌症研究计划。目前，MMCCOP联盟代表着大都市和明尼苏达地区的21家医院和诊所，拥有共同的方法和建立的机制，以识别、招募和跟踪NC赞助的治疗、癌症预防、癌症控制和症状管理方案的参与者。MMCCCP社区的医疗市场仍然竞争激烈，并因合并和明尼苏达州的医疗改革举措而不断变化。尽管环境不断变化，MMCCOP医院和相关工作人员仍在继续合作，支持临床研究试验中增加的时间和费用。在医院内的许多其他项目被减少或取消的时候，他们的支持程度有所增加。该计划纳入了肿瘤学社区的相当一部分，并为执业肿瘤学家、他们的医院管理部门和该联盟中的其他卫生专业人员之间的沟通提供了基础。加在一起，联盟成员平均每年看到超过15,000名新的分析性癌症患者。目前，有146名调查人员，代表内科、血液学、放射和外科肿瘤学，包括胸外科和妇科肿瘤学。MMCCOP研究基地从属关系的历史和积极主动地扩大获得NCI赞助研究的机会的方法支持了实现和保持这一NCORP计划的NCI目标的能力。MMCCOP计划打算维持一个区域范围的社区联盟，向社区提供癌症预防、治疗、症状管理和护理提供方面的最新进展。这将通过以下方式实现：继续与ALL1ANCE、CTSU、ECOG-ACRIN、NRG、MD Anderson、URCC和CCCWFU建立联系；扩展目前的MMCCOP数据管理和通信系统，以增加研究人员参与应计、计划运作和研究基地活动的数量和水平；实施新战略，以改善未得到充分代表和服务的群体的机会和参与；提高专业和非专业社区对癌症研究好处的认识，并与MMCCOP合作，以实现NCORP的目标。新的重点将是进一步开发和利用财团和社区内的专业知识和数据，以提供数据和进行癌症护理提供研究。所有成员机构都是社区肿瘤学项目机构审查委员会的成员，该委员会由Park Nicollet研究所管理，提供高效和及时的研究审查。在过去的5年里，NCI批准的治疗研究和癌症控制研究分别平均积累了250名患者和400名患者。此外，还有1666名参与者正在进行积极的跟踪或监测。MMCCCOP已经展示了每年按协议录取越来越多的患者的能力，并提议在该奖项的第一年为治疗研究累计260个学分，为癌症控制和癌症护理交付研究提供400个学分，目标是在未来5年增加癌症护理交付研究的注册人数。这是一个经过良好调整的研究联合体，有能力在获奖的第一天充分运作。